Lanthanum Carbonate
Composition
This formulation contain Lanthanum Carbonate as active agent
Indications
It is used to lower phosphate levels in the blood of patients with end-stage renal disease
Side effects
nausea, vomiting, diarrhea, abdominal pain, and constipation
Precautions
should be used cautiously in patients with a history of gastrointestinal disorders.
Contraindications
Contraindications include gastrointestinal conditions such as bowel obstruction.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai